Skip to main content

Nektar Therapeutics

NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000906709

In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 3 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Nektar Therapeutics as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
146
+6 vs. Q3 2024
Shares held
132.9M
−7.87M (−5.6%) vs. Q3 2024
Total value
$123.6M
−$59.4M (−32.5%) vs. Q3 2024
New holders
22
49 more added
Sold out
16
36 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NKTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 146 institutions
Q1 2021: 239 institutionsQ2 2021: 243 institutionsQ3 2021: 243 institutionsQ4 2021: 242 institutionsQ1 2022: 243 institutionsQ2 2022: 230 institutionsQ3 2022: 232 institutionsQ4 2022: 217 institutionsQ1 2023: 197 institutionsQ2 2023: 148 institutionsQ3 2023: 139 institutionsQ4 2023: 127 institutionsQ1 2024: 123 institutionsQ2 2024: 135 institutionsQ3 2024: 140 institutionsQ4 2024: 146 institutionsQ1 2025: 157 institutionsQ2 2025: 109 institutionsQ3 2025: 153 institutionsQ4 2025: 180 institutionsQ1 2026: 216 institutionsQ2 2026: 239 institutions
Value heldQ4 2024: $123.6M
Q1 2021: $3.40BQ2 2021: $2.89BQ3 2021: $3.01BQ4 2021: $2.35BQ1 2022: $947.6MQ2 2022: $693.8MQ3 2022: $561.4MQ4 2022: $381.7MQ1 2023: $121.2MQ2 2023: $79.3MQ3 2023: $85.3MQ4 2023: $67.3MQ1 2024: $105.5MQ2 2024: $168.0MQ3 2024: $182.9MQ4 2024: $123.6MQ1 2025: $84.2MQ2 2025: $197.7MQ3 2025: $820.2MQ4 2025: $732.2MQ1 2026: $1.94BQ2 2026: $2.50B
Institutions holding NKTR and their total value by quarter
QuarterHoldersValue
Q2 2026239$2.50B
Q1 2026216$1.94B
Q4 2025180$732.2M
Q3 2025153$820.2M
Q2 2025109$197.7M
Q1 2025157$84.2M
Q4 2024146$123.6M
Q3 2024140$182.9M
Q2 2024135$168.0M
Q1 2024123$105.5M
Q4 2023127$67.3M
Q3 2023139$85.3M
Q2 2023148$79.3M
Q1 2023197$121.2M
Q4 2022217$381.7M
Q3 2022232$561.4M
Q2 2022230$693.8M
Q1 2022243$947.6M
Q4 2021242$2.35B
Q3 2021243$3.01B
Q2 2021243$2.89B
Q1 2021239$3.40B

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Nektar Therapeutics; share changes are against Q3 2024.

Institutions holding NKTR in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Shay Capital LLC352,204$327.6K0.08%−1,243,072−77.9%Reduced
Ameriprise Financial Inc373,948$347.8K0.00%+92,346+32.8%Added
Citadel Advisors LLC397,041$369.2K0.00%−6,557,929−94.3%Reduced
Bank of New York Mellon Corp410,316$381.6K0.00%00.0%Unchanged
Mackenzie Financial Corp469,769$436.9K0.00%+417,651+801.4%Added
Dimensional Fund Advisors LP493,639$459.2K0.00%−10,585−2.1%Reduced
FMR LLC514,364$478.4K0.00%+127,708+33.0%Added
Wellington Management Group LLP522,409$485.8K0.00%+49,319+10.4%Added
Boothbay Fund Management, LLC555,876$517.0K0.02%+206,908+59.3%Added
Exome Asset Management LLC618,174$574.9K0.43%+618,174New
Invesco Ltd.655,526$609.6K0.00%+8,718+1.3%Added
Diadema Partners LP698,919$650.0K0.73%+698,919New
Goldman Sachs Group Inc727,386$676.5K0.00%−1,056,058−59.2%Reduced
Connor, Clark & Lunn Investment Management Ltd.730,875$679.7K0.00%+80,034+12.3%Added
CM Management, LLC750,000$697.5K0.62%00.0%Unchanged
Morgan Stanley802,342$746.2K0.00%+56,228+7.5%Added
AQR Capital Management LLC833,256$774.9K0.00%+331,666+66.1%Added
Almitas Capital LLC920,225$855.8K0.19%00.0%Unchanged
Armistice Capital, LLC1,024,000$952.3K0.02%+24,000+2.4%Added
Peapod Lane Capital LLC1,107,516$1.03M1.02%+1,107,516New
JPMorgan Chase & Co1,182,995$1.10M0.00%+269,695+29.5%Added
Bridgeway Capital Management, LLC1,292,100$1.20M0.03%−70,000−5.1%Reduced
Northern Trust Corp1,414,984$1.32M0.00%+12,826+0.9%Added
Charles Schwab Investment Management Inc1,466,159$1.36M0.00%+11,991+0.8%Added
Two Sigma Advisers, LP1,486,242$1.38M0.00%−14,000−0.9%Reduced
Two Sigma Investments, LP1,537,355$1.43M0.00%+174,185+12.8%Added
UBS Oconnor LLC1,580,916$1.47M0.04%+430,087+37.4%Added
Deep Track Capital, LP1,975,998$1.84M0.07%−13,946,657−87.6%Reduced
Ikarian Capital, LLC2,029,028$1.89M0.54%+716,623+54.6%Added
Monaco Asset Management SAM2,032,868$1.89M0.84%+35,648+1.8%Added
22NW, LP2,191,750$2.04M1.29%+2,191,750New
Jacobs Levy Equity Management, Inc2,626,961$2.44M0.01%−166,243−6.0%Reduced
Altium Capital Management LP3,000,000$2.79M0.87%+2,988,581+26,172.0%Added
State Street Corp3,272,101$3.04M0.00%−73,632−2.2%Reduced
Renaissance Technologies LLC3,910,786$3.64M0.01%+583,153+17.5%Added
Geode Capital Management, LLC3,957,586$3.68M0.00%−5,497−0.1%Reduced
TCG Crossover Management, LLC4,000,000$3.72M0.36%00.0%Unchanged
Millennium Management LLC4,524,946$4.21M0.00%−536,773−10.6%Reduced
Woodline Partners LP4,974,512$4.63M0.03%+3,242,841+187.3%Added
Primecap Management Co5,540,386$5.15M0.00%−372,067−6.3%Reduced
Eventide Asset Management, LLC6,650,000$6.18M0.11%−2,750,000−29.3%Reduced
Acadian Asset Management LLC7,201,089$6.69M0.02%+1,546,211+27.3%Added
Nantahala Capital Management, LLC7,810,000$7.26M0.51%+3,700,000+90.0%Added
Samlyn Capital, LLC9,667,048$8.99M0.14%+467,097+5.1%Added
Vanguard Group Inc12,328,022$11.5M0.00%−792,771−6.0%Reduced
BlackRock, Inc.16,091,581$15.0M0.00%+122,236+0.8%Added
Acuitas Investments, LLC0$00.00%−1,096,445−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−300,352−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−280,366−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−214,245−100.0%Sold out
Jane Street Group, LLC0$00.00%−91,470−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−79,594−100.0%Sold out
Values First Advisors, Inc.0$00.00%−44,762−100.0%Sold out
Erste Asset Management GmbH0$00.00%−46,800−100.0%Sold out
Storebrand Asset Management AS0$00.00%−30,875−100.0%Sold out
Group One Trading, L.P.0$00.00%−27,138−100.0%Sold out
Valence8 US LP0$00.00%−26,107−100.0%Sold out
Engineers Gate Manager LP0$00.00%−13,398−100.0%Sold out
GWM Advisors LLC0$00.00%−1,500−100.0%Sold out
Founders Capital Management0$00.00%−700−100.0%Sold out
Smartleaf Asset Management LLC0$00.00%−282−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−66−100.0%Sold out